Monroe Biomedical Research - Illustration - Clinical studies - Asthma

Join a breathing treatment study for COPD

A new COPD Treatment study is enrolling patients in the Charlotte and Union County area.

If you are at least 40 and have been diagnosed with COPD, you may be eligible for this clinical research study.

dialogue icon

Medical Oversight

  • 24-hour access to MBR’s doctors/medical staff.
  • World class medical oversight.
  • Free of Charge!
like icon

Free of Charge!

  • Insurance is NOT required to participate.
  • Free services include:
    – Study related medication
    – Doctor’s visits
    – Physical exams
    – Testing
coins icon
  • If you qualify and choose to participate in a study, you will be compensated.
Please see details below!
Monroe Biomedical Research - Hero

“By participating in research, COPD patients join the fight against this debilitating disease, improving the wellbeing of millions who suffer from COPD.


Learn More
Register Today

The first step is to learn more and see if you qualify. After registering, a clinical research coordinator will contact you and answer your questions
Sign up using the link below
Call or text +1 704 283 7359


Visit Our Center
See If You Qualify

Our facility is state of the art.

Visit our center for a prescreening visit to see if you qualify.


What our Patients say about our services

Research facility

Monroe Biomedical


Square feet Dedicated Research Facility


Recreational Area Comfortable Recliners


Free entertainment options


First Class Service from our Nurses and Staff

Free entertainment

Movies and Shows
Personal Tablets
Large Flatscreen TV

High Speed Wifi

Family Friendly

Very Comfortable


Ongoing Treatment Studies

Monroe Biomedical Research - Illustration - Clinical studies - Asthma

Monroe Biomedical Research is an FDA sanctioned clinical trial facility running multiple COPD treatment studies examining different ways to treat COPD.

Moderate to Severe
COPD Treatment Study

Age 40 years or older
for patients who Have been diagnosed with COPD for at least one year
therapy Investigational Medication
COMPENSATION Patients that qualify can receive reimbursement for time/travel
Investigational Treatment
(or Placebo)

This study is trying to determine if an investigational drug (dupilumab, the active product) can reduce the number of COPD exacerbations over a period of 1 year compared to placebo (inactive product). Both are injected subcutaneously i.e. is given under the skin.

You will have a 50:50 chance of getting either product. NOTE: an “investigational drug” means that the FDA has not yet approved the drug for use in COPD even though it has been approved in other respiratory conditions like asthma.

For more information: click here
Included, at no cost
  • Your background/controller medication
  • Study related visits
  • Physical Exams
  • Testing
  • Study Medication

COPD Treatment Study

Age 40 years or older
for patients who Have been diagnosed with COPD
therapy Nebulizer and dry powder inhaler taken daily
COMPENSATION Patients that qualify and choose to participate may receive a stipend up to $450
Treatment details

This study is comparing two FDA approved treatments for COPD and investigating which is better for improving lung function in patients with severe COPD.

The study is comparing the following Medications:

1. Revefenacin (Yupelri):
  • Medication is inhaled in the form of a mist using a nebulizer
2. Tiotropium (Spiriva):
  • Medication is inhaled in the form of a dry powder
For more information: click here
Included, at no cost
  • Study Related Medication
  • Study related visits
  • Physical Exams
  • Testing

Contact Us

Monroe Biomedical Research
343 Venus Street, Monroe, NC 28112

Office Phone: 704-283-7369
Fax: 704-283-7329


Frequently Asked Questions

What is COPD?
  • COPD is caused by long term exposure to gases, particulates, but most often cigarette smoking.
How do I know if I have COPD?
  • If you are suffering from COPD, you may experience shortness of breath, wheezing, excessive mucus, chest tightness, or a lack of energy.
How much will the study cost?
  • There will be zero costs for the study participant to take part in the COPD study.
What if I am uninsured?
  • Proof of insurance is NOT required to participate in this study. All medical oversight over the course of your study participation is included.
What does investigational medication mean?
  • An Investigational medication (also known as investigational new drug) has been approved by the Food and Drug Administration (FDA) for testing in people in a clinical study, but has not been approved for general use, distribution or sale. It is through clinical research that these medications receive full approval by the FDA.
How will I be compensated for participating?
  • Participants receive a check following each study visit. For this study, those that qualify and choose to participate could receive a total payment of up to $450.